DCH vs LZB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
DCH exhibits a critical disconnect between valuation and financial health, highlighted by a weak Piotroski F-Score of 2/9 and a concerning Debt/Equity ratio of 6.64. While the stock appears deeply undervalued on a Forward P/E (6.34) and Price/Sales (0.24) basis, the underlying balance sheet is fragile. Strong earnings surprises and a bullish analyst consensus suggest a potential turnaround, but the lack of revenue growth and poor deterministic health scores make this a high-risk speculative play.
La-Z-Boy exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a conservative debt-to-equity ratio of 0.54. While the current price of $35.21 aligns closely with the Graham Number ($33.86), suggesting defensive fair value, there is a stark divergence from the growth-based intrinsic value of $14.0. The company is currently battling significant earnings contraction (-23.5% YoY) despite modest revenue growth. The outlook is a tug-of-war between a robust balance sheet and deteriorating profitability trends.
Compare Another Pair
Related Comparisons
DCH vs LZB: Head-to-Head Comparison
This page compares Dauch Corporation (DCH) and La-Z-Boy Incorporated (LZB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.